Crossmark

First clinical evaluation of the QIAreach <sup>TM</sup> QuantiFERON-TB for tuberculosis infection and active pulmonary disease

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2021.07.003

Published Online: 2025-03-10

Published Print: 2022-01-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Fukushima, K.

Akagi, K.

Kondo, A.

Kubo, T.

Sakamoto, N.

Mukae, H.
License Information

Version of Record valid from 2022-01-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2021-05-09

Accepted: 2021-07-09

Published: 2025-03-10